184 related articles for article (PubMed ID: 24601770)
1. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents.
Sharma R; Patil S; Maurya P
SAR QSAR Environ Res; 2014; 25(3):189-203. PubMed ID: 24601770
[TBL] [Abstract][Full Text] [Related]
2. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
Sainy J; Sharma R
SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
[TBL] [Abstract][Full Text] [Related]
3. Discovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approaches.
Neves BJ; Bueno RV; Braga RC; Andrade CH
Bioorg Med Chem Lett; 2013 Apr; 23(8):2436-41. PubMed ID: 23499236
[TBL] [Abstract][Full Text] [Related]
4. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Kumari M; Chandra S; Tiwari N; Subbarao N
BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
Shah P; Siddiqi MI
SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
[TBL] [Abstract][Full Text] [Related]
6. CoMFA, CoMSIA, and docking studies on thiolactone-class of potent anti-malarials: identification of essential structural features modulating anti-malarial activity.
Roy KK; Bhunia SS; Saxena AK
Chem Biol Drug Des; 2011 Sep; 78(3):483-93. PubMed ID: 21672165
[TBL] [Abstract][Full Text] [Related]
7. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements of 3-carboxyl-4(1H)-quinolones as potential antimalarials from 2D and 3D QSAR analysis.
Li J; Li S; Bai C; Liu H; Gramatica P
J Mol Graph Model; 2013 Jul; 44():266-77. PubMed ID: 23911994
[TBL] [Abstract][Full Text] [Related]
9. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
Saxena S; Durgam L; Guruprasad L
J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
[TBL] [Abstract][Full Text] [Related]
10. Comparative molecular field analysis and molecular docking studies on novel aryl chalcone derivatives against an important drug target cysteine protease in Plasmodium falciparum.
Thillainayagam M; Anbarasu A; Ramaiah S
J Theor Biol; 2016 Aug; 403():110-128. PubMed ID: 27185536
[TBL] [Abstract][Full Text] [Related]
11. In silico analysis reveals the anti-malarial potential of quinolinyl chalcone derivatives.
Thillainayagam M; Pandian L; Murugan KK; Vijayaparthasarathi V; Sundaramoorthy S; Anbarasu A; Ramaiah S
J Biomol Struct Dyn; 2015; 33(5):961-77. PubMed ID: 24871811
[TBL] [Abstract][Full Text] [Related]
12. Classification SAR modeling of diverse quinolone compounds for antimalarial potency against Plasmodium falciparum.
Aher RB; Roy K
Comb Chem High Throughput Screen; 2014; 17(5):396-406. PubMed ID: 24372050
[TBL] [Abstract][Full Text] [Related]
13. New quinoline-5,8-dione and hydroxynaphthoquinone derivatives inhibit a chloroquine resistant Plasmodium falciparum strain.
Hussain H; Specht S; Sarite SR; Hoerauf A; Krohn K
Eur J Med Chem; 2012 Aug; 54():936-42. PubMed ID: 22781704
[TBL] [Abstract][Full Text] [Related]
14. Molecular docking and QSAR analyses for understanding the antimalarial activity of some 7-substituted-4-aminoquinoline derivatives.
Shibi IG; Aswathy L; Jisha RS; Masand VH; Divyachandran A; Gajbhiye JM
Eur J Pharm Sci; 2015 Sep; 77():9-23. PubMed ID: 26006759
[TBL] [Abstract][Full Text] [Related]
15. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
[TBL] [Abstract][Full Text] [Related]
16. Triple-layered QSAR studies on substituted 1,2,4-trioxanes as potential antimalarial agents: superiority of the quantitative pharmacophore-based alignment over common substructure-based alignment.
Gupta AK; Saxena AK
SAR QSAR Environ Res; 2013; 24(2):119-34. PubMed ID: 23194465
[TBL] [Abstract][Full Text] [Related]
17. 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA.
Xue CX; Cui SY; Liu MC; Hu ZD; Fan BT
Eur J Med Chem; 2004 Sep; 39(9):745-53. PubMed ID: 15337287
[TBL] [Abstract][Full Text] [Related]
18. Development of docking-based 3D QSAR models for the design of substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors.
Vyas VK; Ghate M
SAR QSAR Environ Res; 2013 Aug; 24(8):625-45. PubMed ID: 23714018
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme.
Adane L; Bharatam PV
J Mol Graph Model; 2009 Nov; 28(4):357-67. PubMed ID: 19796975
[TBL] [Abstract][Full Text] [Related]
20. Docking studies on the binding of quinoline derivatives and hematin to Plasmodium falciparum lactate dehydrogenase.
Cortopassi WA; Oliveira AA; Guimarães AP; Rennó MN; Krettli AU; França TC
J Biomol Struct Dyn; 2011 Aug; 29(1):207-18. PubMed ID: 21696234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
